p.107 抽出テキスト

atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy. Atherosclerosis 2000; 153: 89-98. PMID: 11058703 550. Raal FJ, Honarpour N, Blom DJ, et al. TESLA Investigators. Inhibition of PCSK 9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, doubleblind, placebo-controlled trial. Lancet 2015; 385: 341- 350. PMID: 25282520 551. Cuchel M, Bloedon LT, Szapary PO, et al. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N Engl J Med 2007; 356: 148-156. PMID: 17215532 552. Harada-Shiba M, Ikewaki K, Nohara A, et al. Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia. J Atheroscler Thromb 2017; 24: 402-411. PMID: 28154305 553. Kameyama N, Maruyama C, Kitagawa F, et al. Dietary Intake during 56 Weeks of a Low-Fat Diet for Lomitapide Treatment in Japanese Patients with Homozygous Familial Hypercholesterolemia. J Atheroscler Thromb 2019; 26: 72-83. PMID: 29899183 554. Tromp TR, Hartgers ML, Hovingh GK, et al. Homozygous Familial Hypercholesterolaemia International Clinical Collaborators. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study. Lancet 2022; 399: 719- 728. PMID: 35101175 555. Rosenson RS, Burgess LJ, Ebenbichler CF, et al. Evinacumab in Patients with Refractory Hypercholesterolemia. N Engl J Med. 2020; 383: 2307-2319. PMID: 33196153